{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:07:11Z","timestamp":1793362031867,"version":"4.5.0"},"reference-count":198,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02904","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T15:55:11Z","timestamp":1576857311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":270,"title":["The Role of Opioid Receptors in Immune System Function"],"prefix":"10.3389","volume":"10","author":[{"given":"Toby K.","family":"Eisenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.123.3.1068","article-title":"Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lympohcytes","volume":"123","author":"Wybran","year":"1979","journal-title":"J Immunol."},{"key":"B2","volume-title":"HIV\/AIDS Surveillance Report, 1995","year":"1996"},{"key":"B3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1600-0773.1973.tb01477.x","article-title":"Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex","volume":"32","author":"Terenius","year":"1973","journal-title":"Acta Pharmacol Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/med.2610110402","article-title":"Opioid receptors and endogenous opioid peptides","volume":"11","author":"Simon","year":"1991","journal-title":"Med Res Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1073\/pnas.77.10.6239","article-title":"Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography","volume":"77","author":"Goodman","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/0896-6273(93)90120-G","article-title":"Cloning and pharmacological characterization of a rat \u03bc opioid receptor","volume":"11","author":"Thompson","year":"1993","journal-title":"Neuron."},{"key":"B7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/bj2950629","article-title":"Molecular cloning and expression of a rat \u03ba opioid receptor","volume":"295","author":"Li","year":"1993","journal-title":"Biochem J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The \u03b4-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3940(96)12976-1","article-title":"Novel receptor mechanisms for heroin and morphine-6\u03b2-glucoronide analgesia","volume":"216","author":"Rossi","year":"1996","journal-title":"Neurosci Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","article-title":"Involvement of brain opiate receptors in the immune-suppressive effect of morphine","volume":"83","author":"Shavit","year":"1986","journal-title":"Proc Natl Acad Sci USA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0006-8993(86)91149-2","article-title":"Effects of foot-shock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance","volume":"372","author":"Shavit","year":"1986","journal-title":"Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0889-1591(87)90034-1","article-title":"Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity","volume":"1","author":"Shavit","year":"1987","journal-title":"Brain Behav Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.2749256","article-title":"The periaqueductal gray matter mediates opiate-induced immunosuppression","volume":"245","author":"Weber","year":"1989","journal-title":"Science."},{"key":"B14","first-page":"693","article-title":"Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice","volume":"269","author":"Carr","year":"1994","journal-title":"J Pharmacol Exp Ther."},{"key":"B15","first-page":"1127","article-title":"A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity","volume":"270","author":"Freier","year":"1994","journal-title":"J Pharmacol Exp Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.11.009","article-title":"Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell","volume":"173","author":"Saurer","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jneuroim.2006.05.002","article-title":"Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity","volume":"177","author":"Saurer","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B18","first-page":"633","article-title":"Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats","volume":"277","author":"Fecho","year":"1996","journal-title":"J Pharmacol Exp Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbi.2007.01.001","article-title":"Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment","volume":"21","author":"Franchi","year":"2007","journal-title":"Brain Behav Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Brit J Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1073\/pnas.95.11.6326","article-title":"Abolition of morphine-immunosuppression in mice lacking the \u03bc-opioid receptor gene","volume":"95","author":"Gav\u00e9riaux-Ruff","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00000542-199509000-00008","article-title":"Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers","volume":"83","author":"Yeager","year":"1995","journal-title":"Anesthesiology."},{"key":"B23","first-page":"913","article-title":"Morphine pellet-induced immunomodulation in mice: temporal relationships","volume":"245","author":"Bryant","year":"1988","journal-title":"J Pharmacol Exp Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1210\/endo-128-6-3253","article-title":"Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment","volume":"128","author":"Bryant","year":"1991","journal-title":"Endocrinology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000139266","article-title":"Immunomodulatory effects of in vitro exposure to morphine and its metabolites","volume":"50","author":"Thomas","year":"1995","journal-title":"Pharmacology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology."},{"key":"B27","first-page":"1336","article-title":"Immunosuppression by morphine is mediated by central pathways","volume":"267","author":"Hernandez","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B28","first-page":"1129","article-title":"Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors","volume":"268","author":"Flores","year":"1994","journal-title":"J Pharmacol Exp Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0014-2999(96)00788-1","article-title":"Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration","volume":"318","author":"Flores","year":"1996","journal-title":"Eur J Pharmacol."},{"key":"B30","first-page":"883","article-title":"Alterations of immune functions in heroin addicts and heroin withdrawal subjects","volume":"286","author":"Govitrapong","year":"1998","journal-title":"J Pharmacol Exp Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/0024-3205(75)90458-0","article-title":"Effects of certain abused drugs on hemolysin forming cells","volume":"17","author":"Lefkowitz","year":"1975","journal-title":"Life Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.126.3.423","article-title":"Immunization of dissociated spleen cell cultures from normal mice","volume":"126","author":"Mishell","year":"1967","journal-title":"J Exp Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/08923979209005416","article-title":"Differential effects of morphine and naltrexone on the antibody response in various mouse strains","volume":"14","author":"Bussiere","year":"1992","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B34","first-page":"591","article-title":"Cytokine reversal of morphine-induced suppression of the antibody response","volume":"264","author":"Bussiere","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S1567-5769(01)00128-X","article-title":"Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses","volume":"1","author":"Rahim","year":"2001","journal-title":"Int Immunopharm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000199887","article-title":"The effect of opiates on the intestinal immune response to cholera toxin in mice","volume":"44","author":"Dinari","year":"1989","journal-title":"Digestion."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.4049\/jimmunol.167.7.3677","article-title":"Morphine inhibits mucosal antibody responses and TGF-\u03b2 mRNA in gut-associated lymphoid tissue (GALT) following oral cholera toxin in mice","volume":"167","author":"Peng","year":"2001","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1749-6632.1990.tb40501.x","article-title":"Immunosuppression to tetanus toxoid induced by implanted morphine pellets","volume":"594","author":"Eisenstein","year":"1990","journal-title":"Ann N Y Acad Sci."},{"key":"B39","first-page":"341","article-title":"Opiate receptor mediated regulation of the immune response in vivo","volume":"48","author":"Weber","year":"1987","journal-title":"NIDA Res Mono Ser."},{"key":"B40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/brbi.1994.1003","article-title":"Morphine-induced decreases in in vivo antibody responses","volume":"8","author":"Lockwood","year":"1994","journal-title":"Brain Behav Immun."},{"key":"B41","first-page":"923","article-title":"Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism","volume":"262","author":"Pruett","year":"1992","journal-title":"J Pharmacol Exp Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1073\/pnas.88.2.360","article-title":"Immunomodulatory activity of \u03bc- and \u03ba-selective opioid agonists","volume":"88","author":"Taub","year":"1991","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","first-page":"1484","article-title":"Mouse strain differences in immunosuppression by opioids in vitro","volume":"275","author":"Eisenstein","year":"1995","journal-title":"J Pharmacol Exp Ther."},{"key":"B44","first-page":"410","article-title":"Suppressive effects of morphine pellet implants on in vivo parameters of immune function","volume":"255","author":"Bryant","year":"1990","journal-title":"J Pharmacol Exp Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0014-4886(86)90148-2","article-title":"Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments","volume":"93","author":"Pellis","year":"1986","journal-title":"Exp Neurol."},{"key":"B46","first-page":"581","article-title":"Chronic morphine administration impairs cell-mediated immune responses in swine","volume":"260","author":"Molitor","year":"1992","journal-title":"J Pharmacol Exp Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/0024-3205(87)90601-1","article-title":"Immunosuppressive effects of chronic morphine treatment in mice","volume":"41","author":"Bryant","year":"1987","journal-title":"Life Sci."},{"key":"B48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/CDLI.4.2.127-132.1997","article-title":"Immunoregulatory effects of morphine on human lymphocytes","volume":"4","author":"Nair","year":"1997","journal-title":"Clin Diag Lab Immunol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.160.4.1886","article-title":"Morphine enhances macrophage apoptosis","volume":"160","author":"Singhal","year":"1998","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/16612","article-title":"Fas-mediated cell death promoted by opioids","volume":"397","author":"Yin","year":"1999","journal-title":"Nature."},{"key":"B51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0014-2999(91)90476-7","article-title":"Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow","volume":"195","author":"Roy","year":"1991","journal-title":"Eur J Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.intimp.2008.01.002","article-title":"Opioids modulate constitutive B-lymphocyte secretion","volume":"8","author":"Vassou","year":"2008","journal-title":"Int Immunopharm."},{"key":"B53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0008-8749(90)90326-M","article-title":"Morphine-induced immune alterations in vivo","volume":"126","author":"Arora","year":"1990","journal-title":"Cell Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4615-2980-4_6","article-title":"Immune alterations in morphine-treated Rhesus monkeys","volume":"267","author":"Carr","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1476-5381.2011.01475.x","article-title":"Depletion and recovery of lymphoid subsets following morphine administration","volume":"164","author":"Zhang","year":"2011","journal-title":"Brit J Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1067\/msy.2001.116033","article-title":"Morphine directs T cells toward Th2 differentiation","volume":"130","author":"Roy","year":"2001","journal-title":"Surgery."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1111\/j.1476-5381.2011.01513.x","article-title":"Opioids and the immune system: what is their mechanism of action?","volume":"164","author":"Eisenstein","year":"2011","journal-title":"Brit J Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/0192-0561(85)90049-9","article-title":"Morphine and methadone impact on human phagocytic physiology","volume":"7","author":"Tubaro","year":"1985","journal-title":"Int J Immunopharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0024-3205(93)90122-J","article-title":"Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages","volume":"53","author":"Rojavin","year":"1993","journal-title":"Life Sci."},{"key":"B60","first-page":"703","article-title":"Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids","volume":"267","author":"Szabo","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4049\/jimmunol.174.1.426","article-title":"Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection","volume":"174","author":"Wang","year":"2005","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0143-4179(91)90161-B","article-title":"Inhibition of phagocytosis in peritoneal macrophages","volume":"18","author":"Casellas","year":"1991","journal-title":"Neuropeptides."},{"key":"B63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jneuroim.2003.10.028","article-title":"Morphine inhibits Fc-mediated phagocytosis through mu and delta opioid receptors","volume":"147","author":"Tomassini","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.ajpath.2011.11.034","article-title":"Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-. Rac-1-, and p38 MAPK-dependent mechanisms","volume":"180","author":"Ninkovi\u0107","year":"2012","journal-title":"Am J Pathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0165-5728(94)90043-4","article-title":"Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells","volume":"50","author":"Peterson","year":"1994","journal-title":"J Neuroimmunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0042-6822(03)00015-1","article-title":"\u03bc-Opioid modulation of HIV-1 coreceptor expression and HIV-1 replication","volume":"309","author":"Steele","year":"2003","journal-title":"Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fmicb.2015.01230","article-title":"Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages","volume":"6","author":"Wang","year":"2015","journal-title":"Front Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/338011","article-title":"Methadone enhances human immunodeficiency virus infection of human immune cells","volume":"185","author":"Li","year":"2002","journal-title":"J Infect Dis."},{"key":"B69","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.4049\/jimmunol.138.11.3907","article-title":"Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity","volume":"138","author":"Peterson","year":"1987","journal-title":"J Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0192-0561(93)90057-6","article-title":"Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures","volume":"15","author":"Chao","year":"1993","journal-title":"Int J Immunopharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1172\/JCI113140","article-title":"Opioid-mediated suppression of interferon-\u03b3 production by cultured peripheral blood mononuclear cells","volume":"80","author":"Peterson","year":"1987","journal-title":"J Clin Invest."},{"key":"B72","first-page":"19","article-title":"Morphine potentiates transforming growth factor-\u03b2 release from human peripheral blood mononuclear cell cultures","volume":"262","author":"Chao","year":"1992","journal-title":"J Pharmacol Exp Ther."},{"key":"B73","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.4049\/jimmunol.152.12.5845","article-title":"Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo","volume":"152","author":"Fecho","year":"1994","journal-title":"J Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/978-1-4615-1951-5_20","article-title":"Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation","volume":"272","author":"Fecho","year":"1995","journal-title":"J Pharmacol Exp Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.1038\/srep11389","article-title":"Morphine modulates interleukin-4 or breast cancer cell-induced pro-metastatic activation of macrophages","volume":"5","author":"Khabbazi","year":"2015","journal-title":"Nat Sci Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bcp.2013.05.027","article-title":"Morphine mediates a proinflammatory phenotype via \u03bc-opioid receptor-PKC\u03b5-Akt-ERK1\/2 signalling pathway in activated microglial cells","volume":"86","author":"Merighi","year":"2013","journal-title":"Biochem Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/1873-3468.12313","article-title":"The activation of \u03bc-opioid receptor potentiates LPS-induced NF-\u03baB promoting an inflammatory phenotype in microglia","volume":"590","author":"Gessi","year":"2016","journal-title":"FEBS Lett."},{"key":"B78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1124\/jpet.118.252890.","article-title":"Coadministration of chemokine receptor antagonists with morphine potentiates morphine's analgesic effect on incisional pain in rats","volume":"367","author":"Inan","year":"2018","journal-title":"J Pharmacol Exp Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1744-8069-3-28","article-title":"Morphine reduces local cytokine expresssion and neutrophil infiltration after incision","volume":"3","author":"Clark","year":"2007","journal-title":"Mol Pain."},{"key":"B80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1189\/jlb.72.1.43","article-title":"Differential morphine tolerance development in the modulation of macrophage cytokine production in mice","volume":"72","author":"Limiroli","year":"2002","journal-title":"J Leukoc Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1189\/jlb.0406237","article-title":"Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes","volume":"81","author":"Martucci","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1038\/tp.2016.4","article-title":"MiR-582-5p\/miR-590-5p targeted CERB1\/CREB5-NF-kB signaling and caused opioid-induced immunosuppression in human monocytes","volume":"6","author":"Long","year":"2016","journal-title":"Translat Psych."},{"key":"B83","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1006\/bbrc.1998.8415","article-title":"Morphine modulates NF-\u03baB activation in macrophages","volume":"245","author":"Roy","year":"1998","journal-title":"Biochem Biophys Res Comm."},{"key":"B84","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.micpath.2010.07.006","article-title":"Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is \u03bc-opioid receptor dependent","volume":"49","author":"Breslow","year":"2010","journal-title":"Microb Pathog."},{"key":"B85","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/IAI.00914-09","article-title":"Morphine disrupts interleukin-23 (IL-23)\/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection","volume":"78","author":"Ma","year":"2010","journal-title":"Infect Immun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"10225","DOI":"10.1074\/jbc.M110.188680","article-title":"Morphine inhibits dendritic cell IL-23 production by modulating toll-like receptor 2 and Nod2 signaling","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0162-3109(91)90042-W","article-title":"Effect of high doses of morphine on Con-A induced lymphokine production in vitro","volume":"22","author":"Jessop","year":"1991","journal-title":"Immunopharm."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/cimm.1997.1147","article-title":"Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes","volume":"179","author":"Roy","year":"1997","journal-title":"Cell Immunol."},{"key":"B89","first-page":"1071","article-title":"Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone","volume":"265","author":"Lysle","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/mvre.2000.2253","article-title":"Morphine attenuates leukocyte\/endothelial interactions","volume":"60","author":"Ni","year":"2000","journal-title":"Microvasc Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1096\/fj.201700546R","article-title":"Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion","volume":"31","author":"Xie","year":"2017","journal-title":"FASEB J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2353\/ajpath.2010.090621","article-title":"Morphine suppresses tumor angiogenesis through a HIF-1\u03b1\/p38MAPK pathway","volume":"177","author":"Koodie","year":"2010","journal-title":"Am J Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cellimm.2010.08.002","article-title":"Chronic morphine treatment inhibits LPS-induced angiogenesis: Implications in wound healing","volume":"265","author":"Martin","year":"2010","journal-title":"Cell Immunol."},{"key":"B94","first-page":"998","article-title":"Activation of mu opioid receptors inhibits microglial cell chemotaxis","volume":"281","author":"Chao","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.4049\/jimmunol.169.7.3589","article-title":"Morphine regulates gene expression of \u03b1- and \u03b2-chemokines and their receptors on astroglial cells via the opioid \u03bc receptor","volume":"169","author":"Mahajan","year":"2002","journal-title":"J Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.clim.2005.02.004","article-title":"Morphine modulates chemokine gene regulation in normal human astrocytes","volume":"115","author":"Mahajan","year":"2005","journal-title":"Clin Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/026988110001400307","article-title":"Morphine inhibits human microglial cell production of, and migration towards, RANTES","volume":"14","author":"Hu","year":"2000","journal-title":"J Psychopharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/glia.20148","article-title":"Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat","volume":"50","author":"El-Hage","year":"2005","journal-title":"Glia."},{"key":"B99","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1471-4159.2008.05756.x","article-title":"Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation","volume":"108","author":"Turchan-Cholewo","year":"2009","journal-title":"J Neurochem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/glia.20262","article-title":"HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines","volume":"53","author":"El-Hage","year":"2006","journal-title":"Glia."},{"key":"B101","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jneuroim.2008.04.021","article-title":"Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor","volume":"197","author":"Finley","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"9917","DOI":"10.1523\/JNEUROSCI.0870-12.2012","article-title":"Morphine modulation of Toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae","volume":"32","author":"Dutta","year":"2012","journal-title":"J Neurosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jneuroim.2007.03.021","article-title":"The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells","volume":"186","author":"Davis","year":"2007","journal-title":"J Neuroimmunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.4049\/jimmunol.165.11.6519","article-title":"\u03bc-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-\u03b3-inducible protein-10 expression in human peripheral blood mononuclear cells","volume":"165","author":"Wetzel","year":"2000","journal-title":"J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0165-5728(97)00219-1","article-title":"Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations","volume":"83","author":"Eisenstein","year":"1998","journal-title":"J Neuroimmunol."},{"key":"B106","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4049\/jimmunol.154.3.1323","article-title":"Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis","volume":"154","author":"Makman","year":"1995","journal-title":"J Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1476-5381.2012.02075.x","article-title":"Ligand-directed signalling within the opioid receptor family","volume":"167","author":"Pradhan","year":"2012","journal-title":"Brit J Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/bph.12222","article-title":"Efficacy and ligand bias at the \u03bc-opioid receptor","volume":"169","author":"Kelly","year":"2013","journal-title":"Brit J Pharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in achieving opioid analgesia without side effects","volume":"9","author":"Machelska","year":"2018","journal-title":"Front Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bcp.2016.05.014","article-title":"Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor","volume":"113","author":"Thompson","year":"2016","journal-title":"Biochem Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/jim-50-06-03","article-title":"Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor","volume":"50","author":"Guo","year":"2002","journal-title":"J Invest Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0014-5793(02)02746-1","article-title":"Methadone induces CCR5 and promotes AIDS virus infection","volume":"519","author":"Suzuki","year":"2002","journal-title":"FEBS Lett."},{"key":"B113","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0162-3109(99)00188-5","article-title":"Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response","volume":"47","author":"Miyagi","year":"2000","journal-title":"Immunopharm."},{"key":"B114","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1084\/jem.188.2.317","article-title":"Opiates trans-deactivate chemokine receptors: \u03b4 and \u03bc opiate receptor-mediated heterologous desensitization","volume":"188","author":"Grimm","year":"1998","journal-title":"J Exp Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"12729","DOI":"10.1074\/jbc.M300430200","article-title":"Ca2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1073\/pnas.102327699.","article-title":"Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain","volume":"99","author":"Szabo","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B117","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugalcdep.2006.09.010","article-title":"Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats","volume":"88","author":"Chen","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"B118","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bbi.2010.10.020","article-title":"Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periacqueductal gray","volume":"25","author":"Heinisch","year":"2011","journal-title":"Brain Behav Immun."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/j.bja.2019.01.021","article-title":"Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats","volume":"122","author":"Inan","year":"2019","journal-title":"Brit J Anaesth."},{"key":"B120","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbi.2013.11.010","article-title":"Src family kinases involved in CXCL12-induced loss of acute morphine analgesia","volume":"38","author":"Rivat","year":"2014","journal-title":"Brain Behav Imm."},{"key":"B121","doi-asserted-by":"publisher","first-page":"8647","DOI":"10.1021\/acs.jmedchem.5b01245","article-title":"Inhibition of inflammatory and neuropathic pain by targeting a mu opioid receptor\/chemokine receptor 5 heteromer (MOR-CCR5)","volume":"58","author":"Akg\u00fcn","year":"2015","journal-title":"J Med Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13075-018-1661-5","article-title":"A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacological tolerance","volume":"20","author":"Dutta","year":"2018","journal-title":"Arthritis Res Therapy."},{"key":"B123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pain.2011.09.022","article-title":"Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103,which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation","volume":"153","author":"Padi","year":"2012","journal-title":"Pain."},{"key":"B124","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrn3858","article-title":"Opioids and chemokine receptor crosstalk: a promising target for pain therapy?","volume":"16","author":"Melik Parsadaniantz","year":"2015","journal-title":"Nat Rev Neurosci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1006\/excr.2002.5638","article-title":"Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells","volume":"280","author":"Suzuki","year":"2002","journal-title":"Exp Cell Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","article-title":"Heterodimerization and cross-desensitization between the \u03bc-opioid receptor and the chemokine CCR5 receptor","volume":"483","author":"Chen","year":"2004","journal-title":"Eur J Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"20354","DOI":"10.1074\/jbc.M110.177303","article-title":"Protein kinase Czeta mediates mu-opioid receptor-induced cross-desensitization of chemokine receptor CCR5","volume":"286","author":"Song","year":"2011","journal-title":"J Biol Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.180.5.3594","article-title":"Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NFkB signaling","volume":"180","author":"Wang","year":"2008","journal-title":"J Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1111\/pme.12784","article-title":"MicroRNA-873 inhibits morphine-induced macrophage apoptosis by elevating A20 expression","volume":"16","author":"Li","year":"2015","journal-title":"Pain Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/infdis\/161.5.894","article-title":"Serious infections other than human immunodeficiency virus among intravenous drug users","volume":"161","author":"Haverkos","year":"1990","journal-title":"J Infect Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0002-9343(50)90021-0","article-title":"Infections resulting from narcotic addiction","volume":"9","author":"Hussey","year":"1950","journal-title":"Am J Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-67-1-1","article-title":"The major medical complications of heroin addiction","volume":"67","author":"Louria","year":"1967","journal-title":"Ann Int Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/clinids\/11.3.486","article-title":"Infectious complications in drug addicts: seven year review of 269 hospitalized narcotic abusers in Switzerland","volume":"11","author":"Scheidegger","year":"1989","journal-title":"Rev Infect Dis."},{"key":"B134","first-page":"42","article-title":"Opiates and the development of post-injury complications: a review","volume":"1","author":"Schwacha","year":"2008","journal-title":"Int J Clin Exp Med."},{"key":"B135","first-page":"56","article-title":"The contribution of opiate analgesics to the development of infectious complications in trauma patients","volume":"5","author":"Oppeltz","year":"2015","journal-title":"Int J Burn Trauma."},{"key":"B136","doi-asserted-by":"publisher","first-page":"396","DOI":"10.7326\/M17-1907","article-title":"Opioid analgesic use and risk for invasive pneumococcal diseases","volume":"168","author":"Wiese","year":"2018","journal-title":"Ann Int Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/cid\/ciy809","article-title":"Long-acting opioid use and the risk of serious infections: a retrospective cohort study","volume":"68","author":"Wiese","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/art.39462","article-title":"Opioid analgesics and the risk of serious infections among patients with rheumatoid arthritis","volume":"68","author":"Wiese","year":"2016","journal-title":"Arthritis Rheum."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system\u2014friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Brit J Pharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00482-014-1463-x","article-title":"Recommendation of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain","volume":"29","author":"Hauser","year":"2015","journal-title":"Schmertz."},{"key":"B141","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/infdis\/148.4.656","article-title":"Effect of morphine on resistance to infection","volume":"148","author":"Tubaro","year":"1983","journal-title":"J Infec Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00002030-199009000-00006","article-title":"Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures","volume":"4","author":"Peterson","year":"1990","journal-title":"AIDS."},{"key":"B143","first-page":"498","article-title":"Effects of morphine on the pathogenesis of murine Friend retrovirus infection","volume":"272","author":"Veyries","year":"1995","journal-title":"J Pharmacol Exp Ther."},{"key":"B144","first-page":"215","article-title":"The influence of morphine on development of HSV-1 and M-MSV virus infection in mice","volume":"39","author":"Panaslak","year":"1990","journal-title":"Acta Microbiol Pol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2005.10.007","article-title":"Acute morphine exposure potentiates the development of HSV-1-induced encephalitis","volume":"172","author":"Lioy","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/315403","article-title":"Morphine increases susceptibility to oral Salmonella typhimurium infection","volume":"181","author":"MacFarlane","year":"2000","journal-title":"J Infect Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejphar.2006.01.048","article-title":"Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit","volume":"534","author":"Feng","year":"2006","journal-title":"Eur J Pharmacol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1128\/IAI.00208-06","article-title":"Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection","volume":"74","author":"Feng","year":"2006","journal-title":"Infect Immun."},{"key":"B149","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11481-011-9303-6","article-title":"Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection","volume":"6","author":"Breslow","year":"2011","journal-title":"J Neuroimm Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1348-0421.2006.tb03824.x","article-title":"Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine","volume":"50","author":"Asakura","year":"2006","journal-title":"Microbiol Immunol."},{"key":"B151","first-page":"605","article-title":"Lethality of morphine in mice infected with Toxoplasma gondii","volume":"252","author":"Chao","year":"1990","journal-title":"J Pharmacol Exp Ther."},{"key":"B152","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0024-3205(94)00789-6","article-title":"Immunomodulation by morphine in Plasmodium berghei-infected mice","volume":"54","author":"Singh","year":"1993","journal-title":"Life Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000069970","article-title":"Neuroimmunomodulatory effects of morphine in Leishmania donovani-infected hamsters","volume":"10","author":"Singal","year":"2002","journal-title":"Neuroimmunomod."},{"key":"B154","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s11481-007-9094-y","article-title":"Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide","volume":"2","author":"Singh","year":"2007","journal-title":"J Neuroimm Pharmacol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.lfs.2007.11.024","article-title":"Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice","volume":"82","author":"Singh","year":"2008","journal-title":"Life Sci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1046\/j.1360-0443.1998.939139310.x","article-title":"Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment","volume":"93","author":"Durante","year":"1998","journal-title":"Addiction."},{"key":"B157","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-2999(83)90460-0","article-title":"A species difference in the slowing effect of intrathecal morphine on gastrointestinal transit","volume":"94","author":"Vaught","year":"1983","journal-title":"Eur J Pharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1086\/514021","article-title":"Morphine induces sepsis in mice","volume":"176","author":"Hilburger","year":"1997","journal-title":"J Infect Dis."},{"key":"B159","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/275450a0","article-title":"Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock","volume":"275","author":"Holaday","year":"1978","journal-title":"Nature."},{"key":"B160","first-page":"39","article-title":"Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock","volume":"7","author":"Reynolds","year":"1980","journal-title":"Circ Shock."},{"key":"B161","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0165-5728(98)00265-3","article-title":"Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model","volume":"95","author":"Roy","year":"1999","journal-title":"J Neuroimmunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bbi.2003.12.001","article-title":"The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-\u03b1 production","volume":"18","author":"Greeneltch","year":"2004","journal-title":"Brain Behav Immun."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e54040","DOI":"10.1371\/journal.pone.0054040","article-title":"Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner","volume":"8","author":"Meng","year":"2013","journal-title":"PLoS ONE."},{"key":"B164","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1128\/IAI.73.12.7953-7959.2005","article-title":"Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12","volume":"73","author":"Feng","year":"2005","journal-title":"Infect Immun."},{"key":"B165","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2005.03.017","article-title":"Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12","volume":"164","author":"Feng","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.tins.2005.10.001","article-title":"Glia: novel counter-regulators of opioid analgesia","volume":"28","author":"Watkins","year":"2005","journal-title":"Trends Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbi.2008.05.004","article-title":"Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav Immun."},{"key":"B168","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav Immun."},{"key":"B169","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B170","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jpain.2012.02.005","article-title":"(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats","volume":"13","author":"Lewis","year":"2012","journal-title":"J Pain."},{"key":"B171","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TRL-4)","volume":"28","author":"Hutchinson","year":"2008","journal-title":"Eur J Neruosci."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.bbi.2008.07.008","article-title":"Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav Immun."},{"key":"B173","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbi.2016.08.004","article-title":"Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury","volume":"58","author":"Ellis","year":"2016","journal-title":"Brain Behav Imm."},{"key":"B175","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.05.039","article-title":"Why is neuroimmunophamacology crucial for the future of addiction research?","volume":"76","author":"Hutchinson","year":"2014","journal-title":"Neuropharmacology."},{"key":"B176","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","article-title":"The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia","volume":"30","author":"Watkins","year":"2009","journal-title":"Trends Pharmacol Sci."},{"key":"B177","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.1038\/s41598-017-11120-4","article-title":"Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucoronide","volume":"7","author":"Roeckel","year":"2017","journal-title":"Nat Sci Rep."},{"key":"B178","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1742-2094-9-200","article-title":"Neuroexcitatory effects of morphine-3-glucoronide are dependent on Toll-like receptor 4 signaling","volume":"9","author":"Due","year":"2012","journal-title":"J Neuroinflam."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/bph.12028","article-title":"Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4","volume":"168","author":"Stevens","year":"2013","journal-title":"Brit J Pharmacol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbi.2016.12.002","article-title":"Activation of the \u03bc-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice","volume":"61","author":"Xie","year":"2017","journal-title":"Brain Behav Imm."},{"key":"B181","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0304-3959(03)00138-6","article-title":"Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injure in rats: mechanistic implictions of spinal glia and proinflammatory cytokines","volume":"104","author":"Raghavendra","year":"2003","journal-title":"Pain."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1124\/jpet.104.082420","article-title":"Transcriptional and translational regulation of glial activation by morphine in a rodent model of neuropathic pain","volume":"313","author":"Tawfik","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"B183","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fpsyt.2018.00726","article-title":"Microglia express mu opioid receptor: insights from transcriptomics and fluorescent reporter mice","volume":"9","author":"Maduna","year":"2019","journal-title":"Front Psychiatry."},{"key":"B184","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/WNR.0b013e3283522e1b","article-title":"Absence of \u03bc opioid receptor mRNA expression in astrocytes and microglia of rat spinal cord","volume":"23","author":"Kao","year":"2012","journal-title":"NeuroRep."},{"key":"B185","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nm.4262","article-title":"Loss of \u03bc opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia","volume":"23","author":"Corder","year":"2017","journal-title":"Nat Med."},{"key":"B186","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbi.2011.12.010","article-title":"Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages","volume":"26","author":"Franchi","year":"2012","journal-title":"Brain Behav Imm."},{"key":"B187","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00540-012-1469-4.","article-title":"Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4","volume":"27","author":"Fukagawa","year":"2013","journal-title":"J Anesth."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e97361","DOI":"10.1371\/journal.pone.0097361","article-title":"Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence","volume":"9","author":"Mattioli","year":"2014","journal-title":"PLoS ONE."},{"key":"B189","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tips.2014.06.008","article-title":"Translational potential of naloxone and naltrexone as TLR4 antagonists","volume":"35","author":"Skolnick","year":"2014","journal-title":"Trends Pharmacol Sci."},{"key":"B190","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.tips.2014.07.002","article-title":"In vivo veritas: (+)-naltrexones's actions define translational importance. A letter in response to Skolnick et al. \u201cTranslational potential of naloxone and naltrexone as TLR4 antagonists\u201d","volume":"35","author":"Watkins","year":"2014","journal-title":"Trends Pharmacol Sci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41593-019-0421-4","article-title":"Morphine withdrawal recruits lateral habenula cytokine signaling to reduce synaptic excitation and sociability","volume":"22","author":"Valentinova","year":"2019","journal-title":"Nat Neurosci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11481-006-9019-1","article-title":"Effects of opioid tolerance and withdrawal on the immune system","volume":"1","author":"Eisenstein","year":"2006","journal-title":"J Neuroimm Pharmacol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0165-5728(02)00103-0","article-title":"Abrupt or precipitated withdrawal from morphine induces immunosuppression","volume":"127","author":"Rahim","year":"2002","journal-title":"J Neuroimmunol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0165-5728(03)00273-X","article-title":"Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules","volume":"144","author":"Rahim","year":"2003","journal-title":"J Neuroimmunol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jneuroim.2003.10.024","article-title":"Paradoxes of immunosuppression in mouse models of withdrawal","volume":"147","author":"Rahim","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1189\/jlb.0304123","article-title":"Splenic macrophages and B-cells mediate immunosuppression following abrupt withdrawal from morphine","volume":"78","author":"Rahim","year":"2005","journal-title":"J Leukoc Biol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1189\/jlb.68.5.723","article-title":"Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages","volume":"68","author":"Peng","year":"2000","journal-title":"J Leukoc Biol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1189\/jlb.0405222","article-title":"Are chemokines the third major system in the brain?","volume":"78","author":"Adler","year":"2005","journal-title":"J Leukoc Biol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:27:48Z","timestamp":1695544068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":198,"alternative-id":["10.3389\/fimmu.2019.02904"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02904","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"article-number":"2904"}}